Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Jcell by JCyte for Retinitis Pigmentosa (Retinitis): Likelihood of Approval
Jcell is under clinical development by JCyte and currently in Phase II for Retinitis Pigmentosa (Retinitis). According to GlobalData, Phase...